Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Life Sciences Research Tools Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Segmentation

Life Sciences Research—Post COVID-19 Pandemic Round-up

Stakeholder Funding Landscape—Key NIH-funded Institutions

Stakeholder Funding Landscape—NIH Organizational Budgets

Growth Drivers

Growth Restraints

Growth Environment—The NIH Budget Increases–Findings

Growth Environment—The NIH Budget Increases–Findings (continued)

Growth Environment—The NIH Budget Increases–Findings (continued)

Growth Environment—The NIH Budget Increases–Findings (continued)

Growth Environment—Spotlight on Private Sector Deals and OI

Growth Environment—Spotlight on Private Sector Deals and OI (continued)

Growth Environment—Budget Increases

Growth Environment—Laboratory Product Budget Increases (continued)

Growth Environment—2023 Laboratory Product Budget Breakdown and 2024 Trend

Growth Environment—2023 Laboratory Product Budget Breakdown and 2024 Trend (continued)

Growth Environment—Impact of Supply Chain Challenges on Laboratories

Trend 1—The NIH Budget and Its Impact on the Research Tools Industry

Trend 2—With $2.5 Billion, ARPA-H Drives High-risk, High-reward Research

Trend 3—Federal FY 2024 Budget Proposal Reignites Cancer Research

Growth Opportunity 1: Cancer Research

Growth Opportunity 1: Cancer Research (continued)

Growth Opportunity 2: Proteomics

Growth Opportunity 2: Proteomics (continued)

Growth Opportunity 3: Open Innovation

Growth Opportunity 3: Open Innovation (continued)

Growth Opportunity 4: Flow Cytometry

Growth Opportunity 4: Flow Cytometry (continued)

List of Exhibits

Legal Disclaimer